Oxford COVID-19 vaccine to ‘start reaching masses in India by 2021 first quarter’

IANS The Serum Institute of India (SII) will be making one billion doses of Covishield vaccine — the vaccine being developed in collaboration with Oxford University — over the next one year for India and other low-and-middle-income countries. SII CEO Adar Poonawalla told IANS in an interview that “by the first quarter of the next … Continue reading Oxford COVID-19 vaccine to ‘start reaching masses in India by 2021 first quarter’